Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data
-
Published:2024-06
Issue:3
Volume:22
Page:102094
-
ISSN:1558-7673
-
Container-title:Clinical Genitourinary Cancer
-
language:en
-
Short-container-title:Clinical Genitourinary Cancer
Author:
Tomida RyotaroORCID,
Takahashi Masayuki,
Matsushita YutoORCID,
Kojima TakahiroORCID,
Yamana KazutoshiORCID,
Kandori ShuyaORCID,
Bando Yukari,
Nishiyama Naotaka,
Yamashita Shimpei,
Taniguchi HisanoriORCID,
Monji Keisuke,
Ishiyama Ryo,
Tatarano ShuichiORCID,
Masui KimihikoORCID,
Matsuda Ayumu,
Kaneko TomoyukiORCID,
Motoshima Takanobu,
Shiraishi Yusuke,
Kira Satoru,
Murashima Takaya,
Hara Hiroaki,
Matsumura Masafumi,
Kitamura Hiroshi,
Miyake Hideaki,
Furukawa JunyaORCID